Page last updated: 2024-08-26

5-chloro-2'-deoxycytidine and Astrocytoma, Grade IV

5-chloro-2'-deoxycytidine has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aller, A; Alvarez, M; Arnold, D; Burk, R; Dauphinée, M; Greer, S; Knapinska, A; Mas, M; Norris, C; Wozniak, C1

Other Studies

1 other study(ies) available for 5-chloro-2'-deoxycytidine and Astrocytoma, Grade IV

ArticleYear
Five-chlorodeoxycytidine, a tumor-selective enzyme-driven radiosensitizer, effectively controls five advanced human tumors in nude mice.
    International journal of radiation oncology, biology, physics, 2001, Nov-01, Volume: 51, Issue:3

    Topics: Animals; Breast Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; DCMP Deaminase; Deoxycytidine; Deoxycytidine Kinase; Female; Glioblastoma; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasm Proteins; Neoplasms; Prostatic Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Spinal Cord; Tetrahydrouridine

2001